Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Common Stock | Options Exercise | $969K | +5K | +2000% | $193.71 | 5.25K | Aug 20, 2021 | Direct | F1 |
transaction | PSA | Common Stock | Sale | -$1.28M | -3.96K | -75.37% | $323.70 | 1.29K | Aug 20, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Stock Option (right to buy) | Options Exercise | $0 | -5K | -100% | $0.00* | 0 | Aug 20, 2021 | Common Stock | 5K | $193.71 | Direct | F3 |
Id | Content |
---|---|
F1 | Includes 250 deferred stock units. |
F2 | Represents weighted average price. These shares were sold at prices ranging betwen $323.385 and $324.065. Full information regarding the number of shares sold at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer. |
F3 | Stock option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vested in three (3) equal annual installments beginning one (1) year from the date of grant. |